Specialists

COPD Treated with Mepolizumab (Nucala)

Clinical Research Study for COPD Treated with Mepolizumab (Nucala)

Who’s eligible?

  • Patients* aged 40 years or older with COPD for at least one year
  • Patients who are beginning treatment with Mepolizumab (Nucala)
  • Have been on regular inhaled therapy for at least three months
  • At least one year of commitment with regular office visits
  • Patient compensation provided for time and participation

If you are eligible and enroll, you will receive all study-related care at no cost. You will also receive monitoring by a research doctor.

*WWMG patients are welcome to apply. Patients seen outside of WWMG are accepted, however we will need medical records from your treating physician.

web button apply now to participate in a clinical research trial
For additional details or if you have questions, please call (425) 225-2780 or email clinicalresearch@wwmedgroup.com.